NCT03733574View on ClinicalTrials.gov

A Study of LY03005 vs Pristiq

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

July 17, 2018

Study Completion Date

July 26, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

LY03005

Drug: LY03005 80 mg, oral tablets, single dose

DRUG

Pristiq

Drug: Pristiq 50 mg, oral tablets, single dose

Trial Locations (1)

21201

Pharmaron CPC, Inc., Baltimore

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT03733574 - A Study of LY03005 vs Pristiq | Biotech Hunter | Biotech Hunter